Phosphorylcholine cytidyltransferase, the enzyme which catalyzes the transfer of phosphorylcholine to cytidine 5'-triphosphate to form CDP-choline, was studied for the first time in human neonatal lung. The assay of product synthesis was linear for 10-20 min and up to 12 mg protein. The pH optimum was 6-6.5. The K, of CTP was 2.0 X 1 o -~ M, and the K, of phosphorylcholine was 0.25 X M. The true Vma, was 10 nmol CDP-cholinejmg protein/lO min. The enzyme was stable under frozen conditions. Oxygen had no apparent affect on enzyme activity.
Speculation
In some tissues, phosphorylcholine cytidyltransferase is ~ossibly the site for a feedback control mechanism of lecithin synthesis. Since there is a relationship between pulmonary lecithin synthesis and neonatal respiratory distress syndrome, purification and characterization of phosphorylcholine cytidyltransferase from human neonatal lung may be of significance.
Lecithin is a major component of lung alveolar surfactant (8, 20, 22, 24) , and a relationship between lung surfactant and neonatal respiratory distress has been established (1, 4, 9, 10, 12, 15) . Lung surfactant activity accompanies increased lecithin biosynthesis in the developing fetus of several species (13, 14, 28) , and lung extracts from infants dying of respiratory distress with alveolar hyaline membranes have abnormal surface active properties (1 5, 20) . De novo lecithin synthesis in lung tissue of experimental animals occurs by at least two pathways ( 1 ) the formation of phosphorylcholine and its transfer from cytidine diphosphorylcholine (CDPcholine) to 1,2-diacyl-sn-glycerol (DaB-diglyceride) (3, 5, 17, 27), and (2) the trimethylation of ethanolamine phosphoglyceride (7, 14, 19) .
Lecithin biosynthesis in human neonatal lung is being investigated indirectly by assaying the enzyme activities of the pathways. Preliminary characterization of phosphorylcholine cytidyltransferase (EC 2.7.7.15), the enzyme responsible for the second step in the CDP-choline pathway, is reported here. Although briefly studied in the rat (26) , this enzyme has not been studied previously in the human lung.
EXPERIMENTAL PROCEDURE CTP (32) and MgC1, (33) were used without further purification to prepare a MgCTP solution at 30 mM in both magnesium and CTP. The pH was adjusted to 7.0 by dropwise addition of NaOH.
Radioactive 1,2-[' 4~] phosphorylcholine with a specific activity of 117 mCi/mM (34) was diluted to 20 pCi/ml and 1.0-ml aliquots were stored in a freezer at -12 until use. Unlabeled phosphorylcholine (100 mM) in phosphate buffer (0.067 M, pH 7.4) was also frozen until the reaction solution was prepared by mixing equal volumes of unlabeled and radioactive phosphorylcholine, producing a solution 50 mM in phosphorylcholine with a specific activity of 10 pCi/ml.
Lung tissue was obtained at autopsy froom neonates 1-7 hr after death and immediately frozen at -12 . Just before use, a piece of lung was weighed and homogenized in a glass mortar with a motor-driven Teflon pestle in 3 volumes of phosphate buffer (0.067 M, pH 7.4). Fresh homogenate was prepared for each assay unless otherwise indicated. The assay used was similar to that described (6) with some modifications. The standard assay mixture contained 3-10 mg tissue homogenate protein, Tris-succinate (8 mM, pH 7.5), and 1,2-[ ' C] phosphorylcholine (1 pCi, 5 mM). This mixture was preincubated for 5 min at 37', then the reaction was started by the addition of MgCTP to a final concentration of 6 mM. The final volume of the incubation mixtuze was 1.0 ml. The samples were incubated for 10 min at 37 , and the reaction was stopped by placing the tubes in a boiling water bath for 5 min. Blanks containing homogenate and buffer were boiled for 5 min and then treated as for the other samples. The boiled reaction mixtures were cooled in ice, then after centrifuging for 5 min at 2,500 X g, 0.50 ml supernatant was withdrawn and delivered to a clean centrifuge tube. The reaction product, radioactive CDP-choline, was separated from substrate 1,2-[ ' C] phosphorylcholine by adsorption of the former on Norit A charcoal (32) . The charcoal was washed four times with unlabeled phosphorylcholine to insure removal of unreacted radioactive phosphorylcholine, and the pellet from the final washing was dried for 1 hr at 60°. After cooling, 1.0 ml formic acid was added, and the pellet was resuspended, mixed, and then centrifuged (5 min, 2,500 X g). One-half milliliter of the supernatant, which contained 1,2-[14c] CDPcholine (6) was delivered to 15 ml scintillation solution (3.3 g 3,5-diphenyloxazole in 400 ml toluene plus 200 ml ethylene glycol monomethyl ether). The samples were counted in a Beckman CMP-100 room temperature liquid scintillation system. Variable quenching was accounted for by the external standard channels ratio method.
Of the charcoal, 92% was retained through the washings and supernatant withdrawals, and the results were corrected for the 8% loss of product. Negligible amounts (<I%) of radioactivity as lecithin were isolated by thin layer chromatography even after 90 min of incubation, so significant product loss through further reactions did not occur. Protein determinations were done by the biuret method. After correcting for counting efficiency, 1,2-[l C] phosphorylcholine, and using the known specific activity of the 1 ,2-[14c] phosphorylcholine, the results were expressed in nanomoles of CDPcholine per milligram of protein per 10-min incubation. Duplicates were within 2-5% of one another.
A blank was always run with each assay since the blank value varied directly with the concentration of substrate and inversely with the amount of protein present in the assay mixture. In addition, the enzyme levels stated are 10% below their actual value since some 10% of the product (1,2-[' C] CDP-choline) was bound to heat-denatured protein at the levels of protein used in routine assays. Relative velocities and K, values are accurate, however, since in the kinetic constant experiments, a large amount of homogenate from the same tissue was prepared and frozen in aliquots suitable for each day's experiment, a process which took 4 days. The enzymatic acti-~ity of the homogenate was not expected to change in that perfod and the percentage product loss because of absorption onto homogenate protein was constant f o~ each experiment.
RESULTS
Product synthesis was linearly dependent upon the amount of tissue homogenate protein added t o the reaction mixture up to 12 mg protein. Activity was linear for 10-20 min, but slowed slightly at incubation times above 20 min. The pH optimum was in the region of 6.5 ( Fig. 1) .
Activity was maximal near 50° ( Table 1 ). The effect of frozen storage was determined by homogenizing and assaying a portion of a lung sample 1-hr postmortem and later. This homogenate was frozen and assayed again at 6 and 13 days. Another portion of the 1-hr postmortem tissue was frozen and also assayed at 6 and 13 days, and a fresh homogenate was prepared each time. A 7-hr postmortem sample of the same tissue was obtained, frozen, and also assayed at 6 and 13 days using fresh homogenate each time. The data in Table 1 show that freezing homogenate or whole tissue for 13 days did not effect activity, nor was there any difference in activity from the tissue removed 1 or 7 hr postmortem. Tissue has now been frozen for over 6 weeks without loss of activity.
Oxygen had no apparent effect on enzyme activity during the 10-min assay time period (Table 1) . Whole homogenate ' Average of duplicate analyses, differing by less than 5%.
Theassay comparing the effect of 0, and N, on enzymatic activity was performed in Warburg flasks using twice the amount of reactants as usual. The reaction mixtures were preincubated and the reaction carried out under their respective atmospheres. The reaction was stopped by pouring the contents of the flask into a centrifuge tube and boiling for 5 min. The flasks were rinsed with 1.0 ml H,O and this washing was added to the tube in the boiling water.
3Storedat -12O. 4Standard assay conditions as described in the text, average of duplicate samples. contained 3 times as much activity as the supernatant obtained after centrifugation at 2,500 X g. Addition of boiled precipitate did not enhance the activity in supernatant.
Enzyme activity was determined over a range of CTP concentrations (0.30-6.0 mM), keeping the phosphorylcholine concentration at 5.0 mM. Activity reached a maximum at about 3.0 mM. The classical Lineweaver-Burk plot (Fig. 2, top) gave V, , , of 4.0 nmol/mg protein/lO min and a K, for CTP of 2.0 X M. Activity was then determined while keeping the CTP concentration at 6.0 mM, as the phosphorylcholine concentration was varied from 0.05 to 5.0 mM:The Lineweaver-Burk plot (Fig. 2, bottom) gave a V, , , = 7.14 nmol/mg protein/lO min, and a K, for phosphorylcholine of 0.25 X M. These are kinetic values relative to the concentration of each substrate, since phosphorylcholine cytidyltransferase catalyzes a bisubstrate reaction. Therefore, to find true kinetic values, initial rates of activity were studied as a function of the concentration of phosphorylcholine at several fixed concentrations of CTP, and vice versa as a function of varying concentrations of phosphorylcholine. These data (Figs. 3 and  \4) indicate that the K, for either substrate varies slightly with the concentration of the second substrate. Secondary plots of the 1 /v intercepts versus l /concentration of fixed substrate) yielded the true V, , , and a K,' for each substrate (Fig. 5) . 
DISCUSSION
The key role of lecithin as the major component of lung surfactant, and its known relationship to respiratory distress syndrome in the human neonate (23) , has led to interest in its biosynthesis in lung (3, 12, 14, 19, 27) . Synthesis by the CDP-choline pathway in lung of experimental animals occurs and recent evidence suggests that the CDP-choline pathway is present in human neonatal lung as we11 (12, 30, 3 1) .
Phosphorylcholine cytidyltransferase, the enzyme responsible for the second step in the CDP-choline pathway, is demonstrated for the first time in human neonatal lung. It has been studied previously in detail in rat and guinea pig liver (6, 11, 25) , chicken peripheral nervous tissue (21) , and has been noted also in rat heart and calf brain (6) and rat lung (26). The assay is described here for maximal velocity, and is reliable by several criteria: (I) linear with protein concentration, (2) linear for 10-20-min incubation, (3) duplicates within f 2-5% (4) minimal loss of product through isolation technique or further reactions. Some loss of reaction product occurred because of absorption onto denatured protein, but the effects of this were minimized by using the same amount of homogenate within each series of experiments.
No loss of activity ozcurred between 1-7 hr under postmortem conditions (4 ). The frozen enzyme was stable and even slightly enhanced, as characteristic of the enzyme from other sources (6) . Some reports have suggested a three-to fourfold enhanced activity after storage in the cold (25) . The pH optimum of 6.0-6.5 was similar to the liver enzyme of 6.0-7.2 (2, 6) . Several enzymes of lung are sensitive to oxygen (16) . However, oxygen had no apparent effect on human neonatal lung phosphorylcholine cytidyltransferase activity during short reaction periods. Phosphorylcholine cytidyltransferase was found in the soluble and microsoma1 (100,000 X g ) fractions by others (2, 11, 21, 25, 28) . The enzyme was not present in the supernatant of the mollusc, but the whole homogenate was not apparently assayed (18) . Only one third of the enzyme activity of human lung was in the supernatant. Possibly incomplete cell disruption was obtained with the glass mortar-Teflon pestle homogenization. Other methods of preparing a more soluble form of the enzyme to facilitate purification procedures need investigation.
The K, for CTP (2.0-2.5 X M) with human lung enzyme is greater than the 0.3 X M reported for rat liver (2, 6) . This discrepancy could be due to the presence of enzymes in the crude human lung homogenate preparation which degrade CTP during the reaction (29) . If so, the actual effective CTP concentration in our system might be less than supposed from the added CTP alone. The K, for phosphorylcholine (0.25-1.0 X M) reported here IS similar to that of 0.5-1 X M reported previously from other tissues (2, 6).
The kinetic constants for human lung phosphorylcholine phosphorylcholine; e--*, cytidyltransferase.
cytidyltransferase were determined in the presence of varying substrate concentrations, which has not been done for the enzyme previously from any source. The nearness of the Km CTP (2.0 X M ) makes it doubtful that previous binding of phosphorylcholine to the enzyme affects subsequent binding of CTP. In contrast, the K,' P-choline (0.25 X M) is enough different from the Km P-choline (1 . O X M) to suggest that previous binding of CTP to the enzyme aids the subsequent binding of phosph~rylcholine. However, these are small differences in kinetic constants in a crude homogenate system. The significance of these findings will depend on further purification and characterization of phosphorylcholine cytidyltransferase from human neonatal lung.
SUMMARY
The enzyme, phosphorylcholine cytidyltransferase, was studied for the first time in homogenates of human neonatal lung. The effect on enzyme activity of protein concentration, pH, frozen homogenate, and frozen whole tissue aging, postmortem aging before obtaining tissue, and oxygen was determined. The kinetic constant for each substrate over varying concentrations of the second substrate was determined and suggested a possible allosteric effect of previous binding of CTP to the enzyme on the subsequent binding of phosphorylcholine. The significance of these findings depends on the separation and isolation of the specific cell type responsible for lecithin biosynthesis and/or further purification of phosphorylcholine cytidyltransferase from human neonatal lung preparations.
